Nebcine (Tobramycin)

Tobramycin, the active ingredient in Nebcine, is an aminoglycoside antibiotic presented as a sterile solution for intramuscular and intravenous use. It treats severe infections caused by susceptible Gram‑negative bacteria, including Pseudomonas aeruginosa, in hospitalised patients. GNH USA supplies Nebcine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nebcine (tobramycin) is employed to combat serious Gram‑negative bacterial infections. - Severe Gram‑negative bacterial infections: provides bactericidal activity against susceptible organisms. - Pseudomonas aeruginosa infections: achieves eradication of this pathogen in respiratory, urinary, or wound sites. - Complicated urinary tract infections: delivers effective bacterial clearance in resistant Gram‑negative UTIs.

Nebcine may cause a range of adverse reactions.

Common Side Effects: - Ototoxicity: transient hearing changes or tinnitus. - Nephrotoxicity: rise in serum creatinine or reduced urine output. - Vestibular toxicity: dizziness or balance disturbances. - Injection site reactions: pain, erythema, or swelling. - Rash or mild skin eruptions.

Serious or Rare Side Effects: - Irreversible hearing loss: permanent auditory damage. - Severe renal injury: acute kidney failure requiring intervention. - Anaphylaxis: life‑threatening allergic reaction. - Respiratory paralysis: especially with neuromuscular blockers. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin detachment. - Persistent neuromuscular blockade: prolonged muscle weakness.

Nebcine requires careful monitoring and specific safety measures. - Renal function monitoring: assess serum creatinine before and during therapy. - Auditory assessment: perform baseline and periodic hearing tests. - Concomitant nephrotoxic drugs: avoid or adjust doses when used together. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Dose adjustment in the elderly: consider reduced clearance. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Nebcine can interact with several medicines, necessitating vigilance.

Major Interactions (Avoid): - Loop diuretics: increase risk of nephrotoxicity. - Vancomycin: additive renal toxicity when co‑administered. - Other aminoglycosides: cumulative toxicity may occur.

Moderate Interactions (Monitor Closely): - NSAIDs: may impair renal clearance of tobramycin. - ACE inhibitors: require monitoring of renal function and electrolytes.